Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Barry E. Greene currently holds 97,340 shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Barry E. Greene has been a net seller of ALNY stock. They have purchased $2.1M and sold $61.3M worth of shares.
Barry E. Greene's most recent insider trade was on Jul 31, 2025, when they sold 53,229 shares at $0.00 per share.
Barry E. Greene serves as Executive at ALNYLAM PHARMACEUTICALS, INC. (ALNY). They have executed 187 insider transactions totaling $63.5M over their tenure at the company.
Barry E. Greene holds the position of Executive at ALNYLAM PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Barry E. Greene has shown a selling trading pattern, with $2.1M in total purchases and $61.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Barry E. Greene was on Oct 22, 2019, when they sold $5.3M worth of ALNY shares. This transaction involved 58,913 shares at $89.99 per share.
Barry E. Greene currently owns 97,340 shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Barry E. Greene's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Barry E. Greene has 187 Form 4 filings on record as an insider at ALNYLAM PHARMACEUTICALS, INC..
Set alerts for Barry E. Greene and 40,000+ other insiders.